EnlargeTheranos reader comments 12 Share this story Theranos has withdrawn its application to the Food and Drug Administration for an emergency clearance of a new diagnostic blood test for Zika virus infections, according to the Wall Street Journal. The FDA’s emergency clearance process, used in times of extraordinary medical need, such as the current...